Long Covid

Clinical research is centered on Long Covid, with attention to persistent symptom burden and recovery challenges following acute infection. The funded work focuses on therapeutic options intended to improve symptom severity and address ongoing functional impairment.

• Post-acute sequelae of SARS-CoV-2 infection
• Symptom severity
• Persistent fatigue
• Functional recovery

The research portfolio reflects interest in repurposed drug approaches for managing chronic manifestations of COVID-19, with a therapeutic emphasis on relieving lingering multisystem symptoms.